Amoy Diagnostics Future Growth
Future criteria checks 3/6
Amoy Diagnostics is forecast to grow earnings and revenue by 20.1% and 19.5% per annum respectively. EPS is expected to grow by 19.7% per annum. Return on equity is forecast to be 17.6% in 3 years.
Key information
20.1%
Earnings growth rate
19.7%
EPS growth rate
| Biotechs earnings growth | 36.2% |
| Revenue growth rate | 19.5% |
| Future return on equity | 17.6% |
| Analyst coverage | Good |
| Last updated | 25 Apr 2024 |
Recent future growth updates
Recent updates
Earnings Report: Amoy Diagnostics Co., Ltd. Missed Revenue Estimates By 6.1%
Apr 24
Amoy Diagnostics (SZSE:300685) Could Easily Take On More Debt
Apr 18What Amoy Diagnostics Co., Ltd.'s (SZSE:300685) 33% Share Price Gain Is Not Telling You
Mar 02Is Amoy Diagnostics Co., Ltd. (SZSE:300685) Worth CN¥22.0 Based On Its Intrinsic Value?
Mar 01Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | 1,857 | 471 | 363 | 402 | 6 |
| 12/31/2025 | 1,565 | 384 | 280 | 287 | 9 |
| 12/31/2024 | 1,278 | 317 | 170 | 232 | 6 |
| 3/31/2024 | 1,082 | 268 | 274 | 312 | N/A |
| 12/31/2023 | 1,044 | 261 | 254 | 299 | N/A |
| 9/30/2023 | 951 | 213 | 222 | 269 | N/A |
| 6/30/2023 | 908 | 301 | 164 | 222 | N/A |
| 3/31/2023 | 831 | 267 | 108 | 189 | N/A |
| 1/1/2023 | 842 | 264 | 71 | 149 | N/A |
| 9/30/2022 | 871 | 287 | 75 | 140 | N/A |
| 6/30/2022 | 911 | 218 | 81 | 146 | N/A |
| 3/31/2022 | 949 | 250 | 88 | 134 | N/A |
| 1/1/2022 | 917 | 240 | 94 | 168 | N/A |
| 9/30/2021 | 890 | 231 | 107 | 196 | N/A |
| 6/30/2021 | 844 | 211 | 125 | 224 | N/A |
| 3/31/2021 | 811 | 198 | 143 | 235 | N/A |
| 12/31/2020 | 728 | 180 | 163 | 221 | N/A |
| 9/30/2020 | 650 | 153 | 114 | 167 | N/A |
| 6/30/2020 | 595 | 138 | 126 | 159 | N/A |
| 3/31/2020 | 550 | 129 | 143 | 170 | N/A |
| 12/31/2019 | 578 | 135 | 128 | 152 | N/A |
| 9/30/2019 | 541 | 140 | 126 | 153 | N/A |
| 6/30/2019 | 502 | 135 | 87 | 120 | N/A |
| 3/31/2019 | 469 | 134 | 66 | 104 | N/A |
| 12/31/2018 | 439 | 127 | 54 | 93 | N/A |
| 9/30/2018 | 398 | 122 | 71 | 108 | N/A |
| 6/30/2018 | 384 | 120 | 88 | 114 | N/A |
| 3/31/2018 | 357 | 103 | 74 | 96 | N/A |
| 12/31/2017 | 330 | 94 | N/A | 92 | N/A |
| 9/30/2017 | 315 | 82 | N/A | 70 | N/A |
| 6/30/2017 | 288 | 78 | N/A | 49 | N/A |
| 3/31/2017 | 258 | 67 | N/A | 40 | N/A |
| 12/31/2016 | 253 | 67 | N/A | 32 | N/A |
| 6/30/2016 | 220 | 42 | N/A | 24 | N/A |
| 3/31/2016 | 198 | 32 | N/A | 22 | N/A |
| 12/31/2015 | 177 | 21 | N/A | 19 | N/A |
| 12/31/2014 | 107 | 19 | N/A | 16 | N/A |
| 12/31/2013 | 74 | 22 | N/A | 9 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: 300685's forecast earnings growth (20.1% per year) is above the savings rate (2.9%).
Earnings vs Market: 300685's earnings (20.1% per year) are forecast to grow slower than the CN market (23.8% per year).
High Growth Earnings: 300685's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: 300685's revenue (19.5% per year) is forecast to grow faster than the CN market (14.4% per year).
High Growth Revenue: 300685's revenue (19.5% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: 300685's Return on Equity is forecast to be low in 3 years time (17.6%).